158
Views
1
CrossRef citations to date
0
Altmetric
Original Research

The Burden, Future Trends, And Economic Impact Of Lung Cancer In Saudi Arabia

ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon & show all
Pages 703-712 | Published online: 19 Nov 2019

References

  • Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386. doi:10.1002/ijc.2921025220842
  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi:10.3322/caac.2010721296855
  • Saudi Health Council. Cancer Incidence Report. The National Saudi Cancer Registry, Riyadh, Saudi Arabia; 2013.
  • Alghamdi HI, Alshehri AF, Farhat GN. An overview of mortality & predictors of small-cell and non-small cell lung cancer among Saudi patients. J Epidemiol Glob Health. 2017.
  • Ibrahim E, Bin SB, Banjar L, Awadalla S, Abomelha MS. Current and future cancer burden in Saudi Arabia: meeting the challenge. Hematol Oncol Stem Cell Ther. 2008;1(4):210–215. doi:10.1016/S1658-3876(08)50006-920058475
  • Alzahrani S Modelling and forecasting lung cancer incidence and mortality in Saudi Arabia [ PhD]. Manchester, UK: University of Salford; 2016.
  • Sari N. Physical inactivity and its impact on healthcare utilization. Health Econ. 2009;18(8):885–901. doi:10.1002/hec.v18:818792089
  • Grootendorst PV. A comparison of alternative models of prescription drug utilization. Health Econ. 1995;4(3):183–198. doi:10.1002/(ISSN)1099-10507550769
  • Weaver CG, Ravani P, Oliver MJ, Austin PC, Quinn RR. Analyzing hospitalization data: potential limitations of Poisson regression. Nephrol Dial Transplant. 2015;30(8):1244–1249. doi:10.1093/ndt/gfv07125813274
  • Van Houtven G, Honeycutt AA, Gilman B, McCall NT, Throneburg WW, Sykes KE. Costs of Illness among Older Adults: An Analysis of Six Major Health Conditions with Significant Environmental Risk Factors. Research Triangle Park, RTI Press, NC. 2008 Sep. RTI Press Research Report Series.
  • Beyene TJ, Mourits MCM, Kidane AH, Hogeveen H. Estimating the burden of rabies in Ethiopia by tracing dog bite victims. PLoS One. 2018;13(2):e0192313. doi:10.1371/journal.pone.019231329466403
  • Bojke L, Manca A, Asaria M, Mahon R, Ren S, Palmer S. How to appropriately extrapolate costs and utilities in cost-effectiveness analysis. Pharmacoeconomics. 2017;35(8):767–776. doi:10.1007/s40273-017-0512-628470594
  • Schreyer P, Koechlin F. Purchasing Power Parities 1999 Benchmark Results. Organization for Economic Co-operation and Development; 2002 Available from: http://www.oecd.org/pdf/M00028000/M00028875.pdf Accessed 114, 2019.
  • Triplett JE. Integrating cost-of-disease studies into purchasing power parities: A Disease-Based Comparison of Health Systems. OECD, Paris, 2003:131.
  • Huber M. International Comparisons of Prices and Volumes in Health Care among OECD Countries. Austria: European Center for Social Welfare Policy and Research; 2006.
  • Levin HM, McEwan PJ. Cost-Effectiveness Analysis: Methods and Applications. Thousand Oaks, CA: Sage Publications Inc.; 2000:328pp.
  • Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Oxford university press; 2015.
  • Salim EI, Jazieh AR, Moore MA. Lung cancer incidence in the arab league countries: risk factors and control. Asian Pac J Cancer Prev. 2011;12(1):17–34.21517227
  • Mourshed M, Hediger V, Lambert T. Gulf cooperation council health care: challenges and opportunities. Global competitiveness reports. 2006.
  • Ng M, Freeman MK, Fleming TD, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980–2012. JAMA. 2014;311(2):183–192. doi:10.1001/jama.2013.28469224399557
  • World Health Organization. WHO Report on the Global Tobacco Epidemic 2015: Raising Taxes on Tobacco: World Health Organization. Geneva, Switzweland: World Health Organization; 2015.
  • Roudi F. Population Trends and Challenges in the Middle East and North Africa. Washington, DC: Population Reference Bureau; 2001.
  • Parkin DM, Bray F, Devesa S. Cancer burden in the year 2000. The global picture. Eur J Cancer. 2001;37:4–66. doi:10.1016/S0959-8049(01)00267-2
  • Devesa SS, Bray F, Vizcaino AP, Parkin DM. International lung cancer trends by histologic type: male: female differences diminishing and adenocarcinoma rates rising. Int J Cancer. 2005;117(2):294–299. doi:10.1002/(ISSN)1097-021515900604
  • Malvezzi M, Carioli G, Bertuccio P, et al. European cancer mortality predictions for the year 2017, with focus on lung cancer. Ann Oncol. 2017;28(5):1117–1123. doi:10.1093/annonc/mdx03328327906
  • Medenwald D, Vordermark D, Dietzel CT. Cancer mortality in former East and West Germany: a story of unification? BMC Cancer. 2017;17(1):94. doi:10.1186/s12885-017-3086-y28148231
  • Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2012. Bethesda: National Cancer Institute; Journal 2015.
  • Cancer registration statistics, England. Cancer Diagnoses and Age-Standardised Incidence Rates for All Types of Cancer by Age and Sex. Office for National Statistics,London, UK, First Release. 2016.
  • Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med. 2011;32(4):605–644. doi:10.1016/j.ccm.2011.09.00122054876
  • Youlden DR, Cramb SM, Baade PD. The international epidemiology of lung cancer: geographical distribution and secular trends. J Thoracic Oncol. 2008;3(8):819–831. doi:10.1097/JTO.0b013e31818020eb
  • Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. doi:10.1371/journal.pmed.003044217132052
  • Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol. 2006;24(28):4539–4544. doi:10.1200/JCO.2005.04.485917008692
  • Menck HR, Henderson BE. Cancer incidence patterns in the Pacific Basin. Natl Cancer Inst Monogr. 1982;62:101–109.7167170
  • Haiman CA, Stram DO, Wilkens LR, et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med. 2006;354(4):333–342. doi:10.1056/NEJMoa03325016436765
  • CotÚ ML, Kardia SL, Wenzlaff AS, Ruckdeschel JC, Schwartz AG. Risk of lung cancer among white and black relatives of individuals with early-onset lung cancer. JAMA. 2005;293(24):3036–3042. doi:10.1001/jama.293.24.303615972566
  • National Cancer Institute. Cancer Trends Progress Report 2014/2015 Update. Health Union, Philadelphia, PA, USA: 2015.
  • Jonsson B, Wilking N. The burden and cost of cancer. Ann Oncol. 2007;18:8–22.
  • Gol-Montserrat J, Del Burgo MLM, Quecedo L, Del Llano JE. Analysis of productivity costs in cancer: a systematic review. Global Reg Health Technol Assess. 2017;4(1):grhta.5000262. doi:10.5301/grhta.5000262